Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 11/20 | 0.50 |
| ▸ | CAPN9 | O14815 | 3/20 | 0.50 |
| ▸ | CTSB | P07858 | 3/20 | 0.50 |
| ▸ | CTSL | P07711 | 3/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CTSH | P09668 | 1/20 | 0.50 |
| ▸ | CTSS | P25774 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CTSG | P08311 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 3/20 | 0.39 |
| ▸ | NPY1R | P25929 | 2/20 | 0.39 |
| ▸ | NPY2R | P49146 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14434209 | 1.00 | CAPN1 (0.50) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL19390995 | 0.86 | CAPN1 (0.47) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL24842411 | 0.82 | CAPN1 (0.64) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL25901224 | 0.81 | CAPN1 (0.45) | CAPN1CAPN9CTSBCTSLCTSK | |
| E-64 SCHEMBL13523481 | 0.81 | CAPN1 (0.74) | CAPN1CAPN9CTSBCTSLCTSK | |
| E-64 SCHEMBL23132676 | 0.81 | CAPN1 (0.74) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL23961738 | 0.81 | CAPN1 (0.50) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL22687572 | 0.81 | CAPN9 (0.53) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL22687573 | 0.81 | CAPN9 (0.53) | CAPN1CAPN9CTSBCTSLCTSK | |
| SCHEMBL20422771 | 0.81 | CAPN9 (0.53) | CAPN1CAPN9CTSBCTSLCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458103-B2 | Compositions and methods for inhibition of cathepsins | MATEON THERAPEUTICS, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150031915-A1 | Compositions and Methods for Inhibition of Cathepsins | MATEON THERAPEUTICS, INC. | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031915-A1 | Compositions and Methods for Inhibition of Cathepsins | CTSF, CTSS, CTSZ | CAPN1 47/4885CAPN9 76/4885CTSB 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.